The Effect of Post-extraction Collagen Sponge Application on Alveolar Osteitis

NCT05850650 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-05-09

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to compare pain, mouth opening, and alveolar osteitis following surgical extraction of bilateral symmetrical impacted lower third molars using two types of wound closures. Collagen plugs will be applied in the sockets of the study side followed by suture, while the controlled side will be sutured without a collagen plug. The study will include 40 patients aged between 18- 40 years old, medically fit (ASA1), who have bilateral symmetrical impacted lower third molars and visit the oral surgery clinics of King Saud Medical City for extraction. The main question is" Does intra-alveolar collagen application after surgical extraction of impacted lower third molars reduce the incidence of alveolar osteitis?

Conditions

  • Alveolar Osteitis

Interventions

OTHER

Application of a collagen sponge after surgical extraction of impacted 3rd molar

Application of a collagen sponge after surgical extraction of impacted 3rd molar

OTHER

No collagen sponge application after surgical extraction of impacted 3rd molar

No collagen sponge application after surgical extraction of impacted 3rd molar

Sponsors & Collaborators

  • Riyadh Colleges of Dentistry and Pharmacy

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-10-15
Completion
2023-11-15

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05850650 on ClinicalTrials.gov